NORTH HAVEN, Conn., Mar 29, 2011 (BUSINESS WIRE) --
Covidien (NYSE: COV), a leading global provider of healthcare products, announced that new data on its laparoscopic surgical products will be presented at SAGES 2011, the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons. Covidien's products will be highlighted in two podium presentations, two video sessions and eight poster presentations. The meeting runs from March 30 to April 2, 2011, at the Henry B. Gonzalez Convention Center in San Antonio, TX.
Located at booth 317, the Company also will demonstrate the latest advancements in general, bariatric and colorectal surgical instrumentation.
Surgeons attending the conference will be able to attend hands-on training in the latest minimally-invasive techniques, including laparoscopic surgery through a single incision, aboard the Covidien Innovation Tour  truck that will be parked at the Covidien booth on the exhibit floor.
SILS(TM) procedures are among the most significant advances in laparoscopic surgery in the last 20 years. The company has replicated a lab environment inside a tractor trailer to provide a mobile training center for laparoscopic surgeons who want to provide innovative surgery to patients but don't have the time to travel to a course. The Innovation Tour training program covers single incision techniques with Covidien's SILS product line and its other surgical tools for minimally-invasive surgery.
For more information, please visit www.covidien.com/SAGES2011 .
Prospective Randomized Controlled Trial of Traditional Four Port Laparoscopic
Cholecystectomy Versus Single Incision Laparoscopic Cholecystectomy (Covidien-sponsored study)
Presenter: Melissa S. Phillips, MD, Resident in Surgery, Department of Surgery, University of Virginia
Health Services, Charlottesville, VA
|Session Number: SS06 Plenary Session I|
|Program Number: S033|
|Session Date: Friday, April 1, 2011|
|Session Time: 7:30 AM - 9:00 AM|
Comparison between RYGB, DS, and VSG Effect on Glucose Homeostasis: Interim Report of
Prospective Study (Covidien-sponsored study)
Presenter: Mitchell S. Roslin, MD, FACS, Chief of the Obesity Surgery Program and Attending,
Department of Surgery, Lenox Hill Hospital, and New York University School of Medicine, New York,
NY and Covidien consultant
|Session Number: SS14 Plenary Session II|
|Program Number: S087|
|Session Date: Saturday, April 2, 2011|
|Session Time: 8:00 AM - 9:30 AM|
Key Clinical Poster Presentations
A Prospective, Single-Center Investigation of the Safety and Performance of the Endo GIA(TM)
Reloads with Tri-Staple(TM) Technology & Endo GIA(TM) Ultra Universal Staplers in a Gastric
Bypass Procedure (Covidien-sponsored study)
Presenter: Samer G. Mattar, MD, FACS, FRCS (Ed), Associate Professor, Indiana University
Department of Surgery and Medical Director, Clarian Bariatrics, Indianapolis, IN and Covidien consultant
|Program Number: P418|
|Date: Friday, April 1, 2011|
|Time: 12:30 PM - 1:30 PM|
Economic Impact of Anastomotic Leaks in Bariatric Procedures in the USA: 2005-2009 (Covidien-sponsored study)
|Presenter: Lobat Hashemi, MS, Manager, Biostatistics, Healthcare Economics & Outcomes Research, Covidien|
|Program Number: P033|
|Date: Friday, April 1, 2011|
|Time: 12:30 PM - 1:30 PM|
Key Covidien products featured at SAGES 2011 include:
SILS Port 
The SILS Port is an advanced surgical product designed to perform laparoscopic surgery through a single incision. This product is designed to give surgeons the ability to use multiple instruments with maximal maneuverability through a single incision.
The SILS port leaves a virtually hidden scar when used in the umbilicus and has the potential to minimize postoperative pain when compared to traditional open procedures.
These latest advancements in endoscopic tissue manipulation enhance the surgeon's flexibility and visualization when performing complex laparoscopic procedures, including SILS procedures. These instruments comprise the SILS Clinch, SILS Hook, SILS Shears and SILS Dissector. Each product offers infinite positions of dynamic articulation within semi-hemispherical space and the ability to lock the instrument shaft and angle through an articulation lock lever.
The SILS Port also works with Covidien's SILS Stitch Articulating Suturing Device .
Covidien's unique black reloads enable surgeons to confidently and consistently staple in extra-thick tissue applications previously beyond the indications of any stapler used for minimally invasive surgery.
Covidien's unique curved tip reload (with optional flexible introducer) provides surgeons with enhanced direct visualization, smooth access to the surgical site, and the ability to dissect and manipulate tissue and vessels in various challenging stapling applications.
This innovative, reusable stapling platform offers microprocessor-controlled precision and push-button control. The RALC was also specially designed to give surgeons deeper access to, and better visibility in, the pelvis1 for low anterior resection procedures.
The V-Loc wound closure device is a revolutionary technology that eliminates the need to tie knots, so surgeons can close incisions up to 50% faster without compromising strength and security. The V-Loc device offers secure, fast and effective wound closure.
The LigaSure 5 mm is a single-use instrument with sealing and cutting capabilities. This blunt tip, laparoscopic sealer/divider combines the signature sealing consistency of LigaSure technology and the longest cutting length available, compared with other commercially available 5 mm laparoscopic sealing devices, with improved grasping.
510(k) clearance pending. With optimized collagen film, innovative textile design and integrated fixation sutures, PCO Optimized delivers optimal protection, integration, fixation and handling for ventral hernia repair.
A sterile, single-use device designed for fixation of prosthetic material, such as hernia mesh, to soft tissues in laparoscopic abdominal wall surgeries and open hernia repair. The tack is constructed of an absorbable synthetic polyester copolymer derived from lactic and glycolic acid.
The EEA Hemorrhoid and Prolapse Stapler Set with DST Series Technology is the next generation of Hemorrhoidopexy. It enables the surgeon with new levels of access, visibility and consistency.
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in three segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2010 revenue of $10.4 billion, Covidien has approximately 42,000 employees worldwide in more than 60 countries, and its products are sold in over 140 countries. Please visit www.covidien.com  to learn more about our business.
1 When compared to EES Contour(R), iDrive & RALC could be placed deeper and provide better visibility in male cadavers; data on file.
Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6663915&lang=en